OUTLOOK THERAPEUTICS INC (OTLK) Forecast, Price Target & Analyst Ratings

NASDAQ:OTLKUS69012T3059

Current stock price

0.2058 USD
+0 (+2.39%)
At close:
0.2038 USD
0 (-0.97%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OUTLOOK THERAPEUTICS INC (OTLK).

Forecast Snapshot

Consensus Price Target

Price Target
$3.95
+ 1,820.55% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q2 / 2026
EPS Estimate
-$0.11
Revenue Estimate
4.488M

ChartMill Buy Consensus

Rating
78.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.95
Upside
+ 1,820.55%
From current price of $0.21 to mean target of $3.95, Based on 10 analyst forecasts
Low
$0.51
Median
$3.57
High
$8.40

Price Target Revisions

1 Month
-27.91%
3 Months
-59.21%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for OTLK. The average price target is 3.95 USD. This implies a price increase of 1820.55% is expected in the next year compared to the current price of 0.2058.
The average price target has been revised downward by 59.21% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

OTLK Current Analyst RatingOTLK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

OTLK Historical Analyst RatingsOTLK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
78.00%
OTLK was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about OTLK.
In the previous month the buy percentage consensus was at a similar level.
OTLK was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11Ascendiant CapitalMaintains Buy -> Buy
2026-02-18Chardan CapitalMaintains Neutral -> Neutral
2026-02-18HC Wainwright & Co.Reiterate Neutral -> Neutral
2026-01-05Chardan CapitalMaintains Neutral -> Neutral
2026-01-02HC Wainwright & Co.Maintains Neutral -> Neutral
2025-12-22Ascendiant CapitalMaintains Buy -> Buy
2025-09-30HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-09-22Ascendiant CapitalMaintains Buy -> Buy
2025-08-29GuggenheimDowngrade Buy -> Neutral
2025-08-29HC Wainwright & Co.Downgrade Buy -> Neutral
2025-08-28Chardan CapitalMaintains Neutral -> Neutral
2025-08-15Chardan CapitalMaintains Neutral -> Neutral
2025-06-06Ascendiant CapitalMaintains Buy -> Buy
2025-02-24Ascendiant CapitalMaintains Buy -> Buy
2025-02-18Chardan CapitalMaintains Neutral -> Neutral
2025-02-18HC Wainwright & Co.Maintains Buy -> Buy
2025-01-17GuggenheimReiterate Buy -> Buy
2025-01-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-02Chardan CapitalDowngrade Buy -> Neutral
2024-11-29BTIGMaintains Buy -> Buy
2024-11-29HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-18BTIGReiterate Buy -> Buy
2024-09-03Ascendiant CapitalMaintains Buy -> Buy
2024-08-16Chardan CapitalMaintains Buy -> Buy
2024-08-15HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q2 / 2026
EPS Estimate
-$0.11
Revenue Estimate
4.488M
Revenue Q2Q
N/A
EPS Q2Q
71.95%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
-11.41%
Revenue (3 Months)
49.15%
EPS (1 Month)
33.33%
EPS (3 Months)
33.33%

Next Earnings Summary

OTLK is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.11 USD and the consensus revenue estimate is 4.49M USD.
The next earnings revenue estimate has been revised upward by 49.15% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
OTLK revenue by date.OTLK revenue by date.
1.414M24.121M
1,606.47%
46.566M
93.05%
23.293M
-49.98%
30.28M
30.00%
30.937M
2.17%
31.609M
2.17%
46.127M
45.93%
47.13M
2.17%
EBITDA
YoY % growth
OTLK ebitda by date.OTLK ebitda by date.
-53.082M
15.56%
-71.589M
-34.87%
-66.945M
6.49%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
OTLK ebit by date.OTLK ebit by date.
-53.126M
15.77%
-71.703M
-34.97%
-67.062M
6.47%
-38.82M
42.11%
-20.989M
45.93%
36.566M
274.22%
-12.278M
-133.58%
-13.606M
-10.82%
-15.177M
-11.55%
-5.415M
64.32%
-5.118M
5.48%
Operating Margin
OTLK operating margin by date.OTLK operating margin by date.
N/AN/A-4,744.37%-160.94%-45.07%156.98%-40.55%-43.98%-48.01%-11.74%-10.86%
EPS
YoY % growth
OTLK eps by date.OTLK eps by date.
-4.80
23.81%
-2.42
49.58%
-0.42
82.64%
-0.63
-49.76%
-0.46
26.49%
-0.15
66.91%
-0.12
20.00%
-0.13
-8.33%
-0.14
-7.69%
-0.04
71.43%
-0.04

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.11
71.95%
-0.11
80.53%
-0.08
57.05%
-0.09
58.27%
-0.09
22.73%
-0.09
19.05%
-0.08
Revenue
Q2Q % growth
4.488M6.732M
347.31%
11.672M
12,786.96%
5.049M
517.96%
5.1M
13.64%
5.406M
-19.70%
5.457M
-53.25%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-10.566M
14.73%
-10.978M
30.29%
-8.871M
48.77%
-7.956M
41.00%
-7.956M
24.70%
-7.65M
30.31%
-7.65M
13.76%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

OTLK Yearly Revenue VS EstimatesOTLK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2025 2026 2027 2028 2029 2030 2031 2032 2033 10M 20M 30M 40M
OTLK Yearly EPS VS EstimatesOTLK Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 -100 -200 -300

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.82%
EPS Next 5 Year
10.99%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
50.35%
Revenue Next 5 Year
35.18%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

OUTLOOK THERAPEUTICS INC / OTLK Forecast FAQ

What is the average price target for OUTLOOK THERAPEUTICS INC (OTLK) stock?

10 analysts have analysed OTLK and the average price target is 3.95 USD. This implies a price increase of 1820.55% is expected in the next year compared to the current price of 0.2058.

Can you provide the upcoming earnings date for OUTLOOK THERAPEUTICS INC?

OUTLOOK THERAPEUTICS INC (OTLK) will report earnings on 2026-05-13.

Can you provide the consensus estimates for OUTLOOK THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of OUTLOOK THERAPEUTICS INC (OTLK) is -0.11 USD and the consensus revenue estimate is 4.49M USD.

Can you provide the analyst count for OUTLOOK THERAPEUTICS INC stock?

The number of analysts covering OUTLOOK THERAPEUTICS INC (OTLK) is 10.